STOCK TITAN

BetterInvesting™ Magazine Update on Vertiv Holdings Co. (NYSE: VRT) and CVS Health Corp. (NYSE: CVS)

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

BetterInvesting Magazine has selected Vertiv Holdings Co. (NYSE: VRT) as its "Stock to Study" for the December 2025 issue, highlighting the company's fundamental data including sales, earnings, pre-tax profit, and return on equity for investor analysis.

Additionally, the magazine will feature a fundamental review of CVS Health Corp. (NYSE: CVS), which the Editorial Advisory and Securities Review Committee considers potentially undervalued and worthy of further study. The committee consists of certified financial analysts and is chaired by editor Doron P. Levin.

BetterInvesting Magazine ha selezionato Vertiv Holdings Co. (NYSE: VRT) come "Stock to Study" per l'edizione dicembre 2025, evidenziando dati fondamentali quali vendite, utili, profitto ante imposte e rendimento sul capitale proprio per l'analisi degli investitori. Inoltre la rivista presenterà una revisione fondamentale di CVS Health Corp. (NYSE: CVS), che il Comitato Editoriale e di Revisione dei Titoli considera potenzialmente sottovalutata e degna di ulteriore studio. Il comitato è formato da analisti finanziari certificati e presieduto dall'editore Doron P. Levin.
BetterInvesting Magazine ha seleccionado Vertiv Holdings Co. (NYSE: VRT) como "Stock to Study" para la edición de diciembre de 2025, destacando sus datos fundamentales como ventas, ganancias, beneficio antes de impuestos y rendimiento sobre el patrimonio para el análisis de inversores. Además, la revista presentará una revisión fundamental de CVS Health Corp. (NYSE: CVS), que el Comité Editorial Asesor y de Revisión de Valores considera potencialmente subvalorada y digna de un mayor estudio. El comité está formado por analistas financieros certificados y está presidido por el editor Doron P. Levin.
BetterInvesting Magazine은 2025년 12월호에서 Vertiv Holdings Co. (NYSE: VRT)을 “Stock to Study”로 선정하여 투자 분석을 위한 매출, 이익, 세전 이익, 자기자본 이익률 등의 기초 데이터를 강조합니다. 또한 CVS Health Corp. (NYSE: CVS)에 대한 기초적 검토를 실을 예정이며, Editorial Advisory and Securities Review Committee가 저평가될 수 있고 추가 연구가 가치 있다고 판단합니다. 위원회는 공인 재무분석가들로 구성되어 있으며 편집자 Doron P. Levin이 의장을 맡고 있습니다.
Le magazine BetterInvesting a choisi Vertiv Holdings Co. (NYSE: VRT) comme « Stock to Study » pour l’édition décembre 2025, en mettant en avant les données fondamentales de l’entreprise telles que les ventes, les bénéfices, le bénéfice avant impôt et le rendement des capitaux propres pour l’analyse des investisseurs. De plus, le magazine présentera une revue fondamentale de CVS Health Corp. (NYSE: CVS), que le Editorial Advisory and Securities Review Committee juge potentiellement sous-évaluée et digne d’une étude plus approfondie. Le comité est composé d’analystes financiers certifiés et est présidé par l’éditeur Doron P. Levin.
BetterInvesting Magazine hat Vertiv Holdings Co. (NYSE: VRT) als „Stock to Study“ für die Ausgabe Dezember 2025 ausgewählt und dabei fundamentale Kennzahlen wie Umsatz, Gewinn, Vorsteuergewinn und Eigenkapitalrentabilität für die Anlegeranalyse hervorgehoben. Zusätzlich wird die Zeitschrift eine fundamentale Überprüfung von CVS Health Corp. (NYSE: CVS) vorstellen, die vom Editorial Advisory and Securities Review Committee als potenziell unterbewertet und weiterer Studien würdig angesehen wird. Das Komitee besteht aus zertifizierten Finanzanalysten und wird von Editor Doron P. Levin geleitet.
اختارت مجلة BetterInvesting شركة Vertiv Holdings Co. (NYSE: VRT) كـ "Stock to Study" في إصدار ديسمبر 2025، مع إبراز بياناتها الأساسية مثل المبيعات والأرباح وربحية ما قبل الضرائب والعائد على حقوق الملكية لتحليل المستثمرين. كما ستتضمن المجلة مراجعة أساسية لـ CVS Health Corp. (NYSE: CVS)، التي يعتبرها لجنة التحرير المستشار واللجنة المختصة بمراجعة الأوراق المالية بأنها مقيمة بشكل محتمل بأقل من قيمتها وتستحق مزيداً من الدراسة. تتكون اللجنة من محللين ماليين معتمدين ويرأسها المحرر Doron P. Levin.
BetterInvesting Magazine 已将 Vertiv Holdings Co. (NYSE: VRT) 评为 2025 年 12 月号的“Stock to Study”,重点关注其基本数据如销售、利润、税前利润和股本回报率,供投资者分析之用。此外,该杂志还将对 CVS Health Corp. (NYSE: CVS) 进行基本面评审,编辑部咨询与证券审查委员会认为其可能被低估,值得进一步研究。委员会由认证金融分析师组成,由编辑 Doron P. Levin 主席。
Positive
  • None.
Negative
  • None.

TROY, Mich., Sept. 30, 2025 /PRNewswire/ -- Vertiv Holdings Co.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine consider Vertiv Holdings Co. (NYSE: VRT) as worthy of further study and has named the company its "Stock to Study" for the December 2025 issue for investors' informational and educational use.

The fundamental data is eye-opening; investors can view Vertiv's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., at: https://ssg.betterinvesting.org/study/ssgplus/?studyid=17125916.

A full report on Vertiv will appear in the December 2025 issue of BetterInvesting Magazine. 

The same issue of BetterInvesting Magazine will also include a fundamental review of CVS Health Corp. (NYSE: CVS), which the independent Editorial Advisory and Securities Review Committee believes is worthy of further study from an undervalued perspective. 

Committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.

Doron P. Levin, an editor of the magazine, serves as the committee's chairperson.

Securities mentioned are for study and presented for educational purposes only. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

About BetterInvesting:

BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org

Follow us on LinkedIn, Instagram and Facebook.

Contact: 877-275-6242

Cision View original content:https://www.prnewswire.com/news-releases/betterinvesting-magazine-update-on-vertiv-holdings-co-nyse-vrt-and-cvs-health-corp-nyse-cvs-302571020.html

SOURCE National Association of Investors/BetterInvesting

FAQ

What stocks did BetterInvesting Magazine select for study in December 2025?

BetterInvesting Magazine selected Vertiv Holdings (VRT) as its 'Stock to Study' and CVS Health (CVS) for fundamental review in the December 2025 issue.

Why is CVS Health (CVS) being reviewed by BetterInvesting Magazine?

CVS Health is being reviewed because the Editorial Advisory and Securities Review Committee believes it is worthy of further study from an undervalued perspective.

Who are the committee members reviewing these stocks for BetterInvesting Magazine?

The committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Anne Nichols, CFA; and Dan Rutter, CFA, with Doron P. Levin serving as chairperson.

Where can investors find fundamental data about Vertiv Holdings (VRT)?

Investors can view Vertiv's fundamental data on the National Association of Investors Corp. website at https://ssg.betterinvesting.org/study/ssgplus/?studyid=17125916.
Vertiv Holdings Co

NYSE:VRT

VRT Rankings

VRT Latest News

VRT Latest SEC Filings

VRT Stock Data

57.61B
380.25M
0.32%
82.22%
2.74%
Electrical Equipment & Parts
Electronic Components, Nec
Link
United States
WESTERVILLE